<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ehlers-Danlos syndromes – 2017 international classification</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ehlers-Danlos syndromes – 2017 international classification</h1>
<div class="graphic"><div class="figure"><div class="ttl">Ehlers-Danlos syndromes – 2017 international classification</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="15%"></colgroup><colgroup width="55%"></colgroup> <tbody> <tr> <td class="subtitle1">Clinical subtype</td> <td class="subtitle1">Old nomenclature</td> <td class="subtitle1">Genetics/inheritance</td> <td class="subtitle1">Predominant features</td> </tr> <tr> <td>Classical EDS (cEDS)</td> <td>Classical EDS, types I and II</td> <td> <p><em>COL5A1</em>, <em>COL5A2</em>, rarely <em>COL1A1</em></p> Autosomal dominant</td> <td> <ul> <li>Hyperextensible skin</li> <li>Atrophic scars, fragile skin, increased bruisability, doughy/velvety skin</li> <li>Generalized joint hypermobility</li> </ul> </td> </tr> <tr> <td rowspan="2">Classical-like EDS (clEDS)</td> <td rowspan="2">TNXB-deficient EDS</td> <td> <p><em>TNXB</em></p> Autosomal recessive</td> <td> <ul> <li><em>TNXB</em> – Hyperextensible skin, velvety skin texture, no atrophic scarring; generalized joint hypermobility, easy bruisability, myopathic features</li> </ul> </td> </tr> <tr> <td> <p><em>AEBP1</em></p> Autosomal recessive</td> <td> <ul> <li><em>AEBP1</em> – Hyperextensible skin, velvety skin texture, atrophic scarring; generalized joint hypermobility, easy bruisability, gastrointestinal rupture <span class="nowrap_whitespace">(rare)<sup>[1]</sup></span></li> </ul> </td> </tr> <tr> <td>Cardiac-valvular EDS (cvEDS)</td> <td> </td> <td> <p><em>COL1A1</em></p> Autosomal recessive</td> <td> <ul> <li>Progressive cardiac valve involvement</li> <li>Hyperextensible thin skin, atrophic scars, increased bruisability</li> <li>Joint hypermobility</li> </ul> </td> </tr> <tr> <td>Vascular EDS (vEDS)</td> <td>Vascular EDS, type IV</td> <td> <p><em>COL3A1</em></p> Autosomal dominant</td> <td> <ul> <li>Arterial rupture</li> <li>Internal organ rupture (colon, uterus)</li> <li>Severe bruising</li> <li>Thin translucent skin</li> <li>Small joint hypermobility</li> </ul> </td> </tr> <tr> <td>Hypermobile EDS (hEDS)</td> <td>Hypermobile EDS, type III</td> <td> <p>Unknown</p> Autosomal dominant</td> <td> <ul> <li>Generalized joint hypermobility</li> <li>Mild hyperextensible skin, soft velvety skin, recurrent hernias, organ prolapse, unexplained striae</li> <li>Chronic pain</li> <li>Joint dislocations/subluxations</li> </ul> </td> </tr> <tr> <td>Arthrochalasia EDS (aEDS)</td> <td>Arthrochalasia, types VIIA and VIIB</td> <td> <p><em>COL1A1</em>, <em>COL1A2</em></p> Autosomal dominant</td> <td> <ul> <li>Congenital bilateral hip dislocation</li> <li>Severe generalized joint hypermobility</li> <li>Hyperextensible skin, tissue fragility</li> <li>Hypotonia</li> <li>Mild osteopenia</li> </ul> </td> </tr> <tr> <td>Dermatosparaxis EDS (dEDS)</td> <td>Dermatosparaxis EDS, type VIIC</td> <td> <p><em>ADAMTS2</em></p> Autosomal recessive</td> <td> <ul> <li>Severe skin fragility, visceral fragility</li> <li>Lax redundant skin</li> <li>Severe bruisability</li> <li>Postnatal growth retardation</li> </ul> </td> </tr> <tr> <td>Kyphoscoliotic EDS (kEDS)</td> <td>Kyphoscoliosis EDS, type VI</td> <td> <p><em>PLOD1</em></p> <p><em>FKBP14</em></p> Autosomal recessive</td> <td> <ul> <li>Congenital hypotonia</li> <li>Early kyphoscoliosis</li> <li>Generalized joint hypermobility</li> <li>Osteopenia</li> <li>Blue sclerae</li> <li>Marfanoid habitus</li> <li>Hearing loss, myopathic features (<em>FKBP14</em> form)</li> </ul> </td> </tr> <tr> <td>Brittle cornea syndrome (BCS)</td> <td>Brittle cornea syndrome</td> <td> <p><em>ZNF469</em></p> <p><em>PRDM5</em></p> Autosomal recessive</td> <td> <ul> <li>Thin cornea</li> <li>Keratoconus</li> <li>Blue sclerae</li> <li>Risk for globe rupture, retinal detachment</li> <li>High myopia</li> </ul> </td> </tr> <tr> <td>Spondylodysplastic EDS (spEDS)</td> <td> <p>EDS progeroid type</p> Spondylocheirodysplastic EDS</td> <td> <p><em>B4GALT7</em></p> <p><em>B3GALT6</em></p> <p><em>SLC39A13</em></p> Autosomal recessive</td> <td> <ul> <li>Short stature</li> <li>Hypotonia</li> <li>Limb bowing, characteristic skeletal findings</li> <li>Osteopenia</li> <li>Hyperextensible, thin doughy skin</li> </ul> </td> </tr> <tr> <td>Musculocontractural EDS (mcEDS)</td> <td> <p>Adducted thumb</p> <p>Clubfoot Syndrome</p> <p>B3GalT6-deficient EDS</p> EDS Kosho type</td> <td> <p><em>CHST14</em></p> <p><em>DSE</em></p> Autosomal recessive</td> <td> <ul> <li>Congenital contractures (clubfoot)</li> <li>Hyperextensible skin, easy bruisability, fragile skin, atrophic scars</li> <li>Recurrent dislocations</li> </ul> </td> </tr> <tr> <td>Myopathic EDS (mEDS)</td> <td> </td> <td> <p><em>COL12A1</em></p> Autosomal dominant or recessive</td> <td> <ul> <li>Congenital hypotonia</li> <li>Proximal joint contractures</li> <li>Distal joint hypermobility</li> <li>Doughy skin</li> <li>Atrophic scars</li> </ul> </td> </tr> <tr> <td>Periodontal EDS (pEDS)</td> <td>EDS periodontitis, type VIII</td> <td> <p><em>C1R</em></p> <p><em>C1S</em></p> Autosomal dominant</td> <td> <ul> <li>Early-onset severe periodontitis</li> <li>Unattached gingiva</li> <li>Pretibial plaques</li> <li>Joint hypermobility</li> <li>Hyperextensible skin</li> <li>Marfanoid features</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>EDS: Ehlers-Danlos syndromes.</p>
* Refer to UpToDate topic review on clinical manifestations and diagnosis of Ehlers-Danlos syndromes and Malfait F, Francomano C, Byers P, et al for complete details about the diagnostic criteria.</div><div class="graphic_reference">Reference:
<ol>
<li>Blackburn PR, Xu Z, Tumelty KE, et al. Bi-allelic alterations in AEBP1 lead to defective collagen assembly and connective tissue structure resulting in a variant of Ehlers-Danlos syndrome. Am J Hum Genet 2018; 102:696.</li>
</ol>
<p class="extra_spacing_top">Modified from: Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017; 175(1):8-26. <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/ajmg.c.31552" target="_blank">https://onlinelibrary.wiley.com/doi/abs/10.1002/ajmg.c.31552</a>. Copyright © 2017. Reproduced with permission of John Wiley &amp; Sons Inc. This image has been provided by or is owned by Wiley. Further permission is needed before it can be downloaded to PowerPoint, printed, shared or emailed. Please contact Wiley's permissions department either via email: <a href="/cdn-cgi/l/email-protection#205045524d495353494f4e536057494c45590e434f4d"><span class="__cf_email__" data-cfemail="166673647b7f65657f79786556617f7a736f3875797b">[email protected]</span></a> or use the RightsLink service by clicking on the 'Request Permission' link accompanying this article on Wiley Online Library (<a href="http://onlinelibrary.wiley.com" target="_blank">http://onlinelibrary.wiley.com</a>).</p></div><div id="graphicVersion">Graphic 118193 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
